glutathione mutations in sclc patients

glutathione mutations in sclc patients NRF2 supports non-small cell lung cancer growth independently of CBP/p300-enhanced synthesis | EMBO Reports Frontiers | Absence of Biomarker-Driven

Name: glutathione mutations in sclc patients NRF2 supports non-small cell lung cancer growth independently of CBP/p300-enhanced synthesis | EMBO Reports Frontiers | Absence of Biomarker-Driven
Brand: centoria.fr
SKU: 9434414119
Price: 25.28 USD
Availability: InStock
Rating: 4.0243 (18 reviews)

Frontiers Absence of Biomarker Driven Treatment Options in Small Cell Lung Cancer, and Selected Preclinical Candidates for Next Generation Combination Therapies JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma Integrated methylome analysis identifies an epigenetically silenced tumor suppressor RASA4 in small cell lung cancer Communications Biology Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small cell lung cancer patients Annals of Oncology

SKU: 9434414119 · From centoria.fr

4.0

USD25.28 USD66.28

Pay in 4 interest-free payments of $6.32 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 24 - Sep 29

Description

The trace file of the sequence obtained from these three subjects was examined and aligned with the published sequence of the human GPX1 gene sequence

It is a partial sequence of a body protective compound (BPC) that was discovered and isolated from human gastric juice

Biochemistry (Mosc) 73:14931510 Kang JS, Choi IW, Han MH, Hong SH, Kim SO, Kim GY, Hwang HJ, Kim BW, Choi BT, Kim CM, Choi YH (2015) Sargassum horneri methanol extract rescues C2C12 murine skeletal muscle cells from oxidative stress-induced cytotoxicity through Nrf2-mediated upregulation of heme oxygenase-1